Single High-dose of Liposomal Amphotericin B in HIV/AIDS-related Disseminated Histoplasmosis: a Randomized Trial ✅ Just Accepted 🔓 Open Access https://t.co/FWgtQ1Lmzi

The meningitis team are incredibly proud of @TugumeLillian for being awarded a @Fogarty_NIH Fellowship to study TB meningitis diagnostics. Dr Lillian is co-PI of HARVEST & has cared for 100s of TBM patients so knows the urgency for better diagnostics @dmeya @IDIMakerere @UMNews

Medics with internal medicine training / MRCP. Fantastic opportunity to work in Botswana with ⁦@AidsHarvard⁩ as Internal Medicine Site Director for Botswana Global Health Program. Would be a wonderful leadership and education role with a lovely team

We are excited to launch our Grant Writing Skills Programme for women in health research African women researchers face additional gender barriers in accessing research funding If you need grant writing skills for your projects then apply by 12 May👉🏾 https://t.co/AxShL7f2ft

Hyponatremia as a predictor of cryptococcal meningitis and death among asymptomatic persons with HIV and cryptococcal antigenemia ✅ Just Accepted 🔓 Open Access 🔗 https://t.co/vS001aYbaI

This Gwyneth Paltrow trial is the whitest s**t Bailiff @roywoodjr has ever seen

Gender, Racial, and Ethnic Inequities Among Recipients of Multiple NIH Research Project Grants https://t.co/sjwvMqi1cf via @JAMANetworkOpen part of @JAMANetwork Recipients of 3 or more @NIH grants are primarily white men.

🚨Job posting🚨 ID Division @DOM_UCLA/@dgsomucla recruiting Physician-Scientist for Assoc/Full Professor. #Research focus on translational science w/ priority in #TxID-related infections Please share & check us out! 🔗: https://t.co/ENwR6ITVoc #physicianscientist #IDtwitter

Effect of Covid-19 lockdowns on identification of advanced HIV disease in outpatient clinics in Uganda Elizabeth Nalintya, Preethiya Sekar,..., David R Boulware, David B Meya, Radha Rajasingham https://t.co/xqcxfCI9j2

Effect of Covid-19 lockdowns on identification of advanced HIV disease in outpatient clinics in Uganda ✅ Just Accepted 🆓 Freely Available 🔗 https://t.co/flpH9hBCKu

@MSFsci @MSF_access @CIDJournal An interactive map of Cryptococcal meningitis incidence around the world can be found at https://t.co/I87jYgRAKw (shameless self-plug)

Cryptococcal meningitis causes of one in five AIDS-related deaths worldwide, but treatment is unaffordable for most low- and middle-income countries @MSF_access advocate for these medicines to be made affordable in this commentary in @CIDJournal #AIDS https://t.co/gcdQ74MBA7

Congrats to David Boulware and David Bisagaya Meya for receiving NIH award, UG3NS131096, 'Encochleated Oral Amphotericin for HIV-related Cryptococcal Meningitis Trial: Phase 3 Trial!'

APPLY now to our 4-year MRes-PhD Studentships in Medical Mycology and Fungal Immunology @MRCcmm @UofE_Research @uniofexeHLS @UoEBiosciences Fully funded with a broad interdisciplinary training not available anywhere else in the world: https://t.co/ZeDo68jWCS Deadline 14th Feb

Calls to urgently increase access to testing for meningitis and PCP in African nations to curb #AIDS related deaths. https://t.co/4oSMrrQWev

Our co-CI @neleshg presenting on CrAg screening programmes, in which the EFFECT trial is embedded. Our other co-CI @Molloy_Sile presented @EffectTrial earlier this morning during the #ICCC2023 Clinical Track CrAg Screening sessions. Working our way to #endcryptodeaths by 2030💉💊

Getting to know each other @ICCC2023 international conference on Cryptococcus and cryptococcosis.

I was honoured to officiate at the opening ceremony of the 11th International Cryptococcus & Cryptococcosis Conference. I congratulate @IDIMakerere & @MakerereCHS for hosting the conference for the first time in Africa. The keynote address by Dr. Chiller of CDC was informative.

Busy and interesting poster session at ICCC2023 yesterday evening

@JNJarvis76 taking us through the "bench to bedside" pipeline for the @ambitioncm2020 An excellent model, and reminder that the work is far from done when the clinical trial is finished. We need access, advocacy and engagement if we want to #endcryptodeaths by 2030🧫🦠🧠